Sumaxin Cloth
NDC Package 43538-100-60
Package Information
Sumaxin (sulfacetamide sodium and sulfur) cloths is sumaxin® (sodium sulfacetamide 10% & sulfur 4%) Cleansing Pads are indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. This formulation utilizes a cloth delivery system. Marketed by Medimetriks Pharmaceuticals, Inc., this product is identified by NDC 43538-100.
Identification & Billing
- RxCUI: 1000946 - sulfacetamide sodium 10 % / sulfur 4 % Medicated Pad
- RxCUI: 1000946 - sulfacetamide sodium 100 MG/ML / sulfur 40 MG/ML Medicated Pad
- RxCUI: 1000946 - sulfacetamide sodium 10 % / sulfur 4 % Topical Swab
- RxCUI: 1000976 - Sumaxin CP 10 % / 4 % Medicated Pad
- RxCUI: 1000976 - sulfacetamide sodium 100 MG/ML / sulfur 40 MG/ML Medicated Pad [Sumaxin]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 43538 - Medimetriks Pharmaceuticals, Inc.
- 43538-100 - Sumaxin
- 43538-100-60 - 60 PACKET in 1 CARTON / 3.7 g in 1 PACKET
- 43538-100 - Sumaxin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43538-100-60 identifies a specific commercial package of 60 packet in 1 carton / 3.7 g in 1 packet of Sumaxin Cleansing Pads, a human prescription drug labeled by Medimetriks Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This cloth is formulated for topical use and contains sulfacetamide sodium; sulfur as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medimetriks Pharmaceuticals, Inc. on January 01, 2009. The current certification is valid through December 31, 2026.
How is this Medimetriks Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43538010060. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.